Tech Company Financing Transactions
Pragma Bio Funding Round
The Venture Collective, CJ Investment and Merck Global Health Innovation Fund participated in a $10 million Series A capital raise for Pragma Bio. The round was announced on 3/23/2023.
Transaction Overview
Company Name
Announced On
3/23/2023
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series A
Investors
Proceeds Purpose
The new funding will be used for this and other scaling efforts; the $10 million isn't the end of this fundraise, but it is a nice round number that the company felt was good to get out there along with its new name. That change, by the way, came with a realignment of the company around putting already beneficial molecules to work (it's a pragmatic approach); the old name suggested more of a gut health kind of thing, so they rebranded.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
280 Utah Ave South
San Francisco, CA Undisclosed
USA
San Francisco, CA Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Overview
Pragma Bio exists to find cures for undruggable immunological disorders. We use real-world data and synthetic biology to map out multi-omic signatures associated with clinical outcomes in order to produce microbial-derived small molecules with therapeutic potential.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kareem Barghouti
Browse more venture capital transactions:
Prev: 3/23/2023: Sparta Science venture capital transaction
Next: 3/23/2023: Coactive AI venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on funding rounds that are announced publicly. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs